Spago Nanomedical
0.13 SEK
+2.86 %
Less than 1K followers
SPAGO
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Spago Nanomedical
EV/S
Median 2019-2022
EV/EBIT
Median 2019-2022
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 9.48 | 5.68 | 3.20 | 0.43 | 0.23 | 0.14 | 0.12 |
| Shares | 33.3 | 47.5 | 61.7 | 134.4 | 266.2 | 491.5 | 661.6 |
| Market cap | 315.4 | 270.0 | 197.7 | 57.3 | 61.7 | 68.2 | 77.1 |
| Enterprise value | 303.3 | 241.6 | 145.2 | -4.8 | - | - | - |
| EV/S | 10,109.5 | 706.3 | 220.0 | neg. | - | - | - |
| EV/EBITDA | neg. | neg. | neg. | 0.1 | - | - | - |
| EV/EBIT | neg. | neg. | neg. | 0.1 | - | - | - |
| P/E | neg. | neg. | neg. | neg. | neg. | neg. | neg. |
| P/B | 2.29 | 1.69 | 1.07 | 0.29 | 1.49 | 2.05 | 2.51 |
| P/S | 10,514.5 | 789.5 | 299.5 | 54.6 | 51.4 | 35.7 | 176.4 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 97.9 % | 98.1 % | 96.4 % | 95.7 % | 78.0 % | 84.0 % | 83.8 % |
| Gearing ratio | - | - | - | - | - | - | - |